MTOR and colorectal carcinoma: Hypoxia, a common and hallmark feature of most tumors, profoundly affects the progression and metastasis of CRC and influences the efficacy of chemotherapy, radiotherapy, and immunotherapy through complex mechanisms, including the mammalian target of rapamycin (mTOR) signaling pathway [22, 23].